by Don McLean | Jul 20, 2020 | News
MMS WINS AWARD FOR MOST INNOVATIVE CLINICAL RESEARCH ORGANIZATION CANTON, Mich. (July 20, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that it has been recognized by Corporate LiveWire as the Most Innovative Clinical Research...
by Don McLean | Jul 10, 2020 | Blog
Why COVID-19 testing devices require a high level of specificity by Patrick Hannon, PhD, Japie Lowings, and Aditya Gadiko Note: To use the dashboard, read the article below, then click the arrows on the dashboard to enter full screen mode. Use the dashboard to find...
by Don McLean | Jun 29, 2020 | Blog
Whitepaper: Pharmaceutical Industry Challenges Facing Clinical Trial Disclosure and Transparency By MMS Holdings and TrialAssure [Fill out the form below to access the whitepaper] While global regulatory authorities routinely update clinical trial disclosure and...
by Don McLean | Jun 11, 2020 | News
Helping to Accelerate the Search for Solutions to the COVID-19 Crisis By Rob DiCicco – Deputy Chief Health Officer, IBM Watson Health, June 11, 2020 The full article can be read on the IBM Watson Health website. An excerpt of the article is below. The novel...
by Don McLean | Jun 9, 2020 | News
IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment THUNDER BAY, ONTARIO (June 09, 2020) — IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the...
